Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues:
Premiums	$ 86,956	$ 87,905	$ 174,517	$ 174,439
Investment and other income	1,223	1,108	2,354	2,141
Total revenues	112,032	111,616	223,753	221,191
Operating costs:
Medical Costs	75,358	78,585	148,847	151,996
Operating costs	14,268	13,778	29,658	27,372
Cost of products sold	13,375	13,019	26,198	25,409
Depreciation and amortization	1,040	1,084	2,069	2,145
Total operating costs	104,041	106,466	206,772	206,922
Earnings from operations	7,991	5,150	16,981	14,269
Interest expense	(962)	(1,027)	(1,917)	(2,025)
Loss on sale of subsidiary and subsidiaries held for sale	(61)	(41)	(133)	(56)
Earnings before income taxes	6,968	4,082	14,931	12,188
Provision for income taxes	(1,298)	(510)	(2,780)	(2,142)
Net earnings	5,670	3,572	12,151	10,046
Earnings attributable to noncontrolling interests	(186)	(166)	(387)	(348)
Net earnings attributable to UnitedHealth Group common shareholders	$ 5,484	$ 3,406	$ 11,764	$ 9,698
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic	$ 6.06	$ 3.76	$ 12.98	$ 10.66
Diluted	$ 6.04	$ 3.74	$ 12.94	$ 10.61
Basic weighted-average number of common shares outstanding	902	907	905	910
Dilutive effect of common share equivalents	4	3	3	4
Diluted weighted-average number of common shares outstanding	906	910	908	914
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	12	13	15	10
Products
Revenues:
Revenue from Products and Services	$ 13,835	$ 13,564	$ 27,085	$ 26,600
Services
Revenues:
Revenue from Products and Services	$ 10,018	$ 9,039	$ 19,797	$ 18,011

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities
Net earnings	$ 12,151	$ 10,046
Noncash items:
Depreciation and amortization	2,069	2,145
Deferred income taxes	411	(87)
Share-based compensation	624	572
Loss on sale of subsidiary and subsidiaries held for sale	133	56
Other, net	(235)	127
Net change in other operating items, net of effects from acquisitions and dispositions:
Accounts receivable	1,481	(1,681)
Other assets	3,020	(2,143)
Medical costs payable	(420)	4,371
Accounts payable and other liabilities	1,152	(480)
Unearned revenues	(422)	(282)
Cash flows from operating activities	19,964	12,644
Investing activities
Purchases of investments	(10,125)	(8,180)
Sales of investments	2,664	5,181
Maturities of investments	4,710	4,326
Cash paid for acquisitions and other transactions, net of cash assumed	(98)	(734)
Purchases of property, equipment and capitalized software	(1,562)	(1,784)
Repayments of care provider loans - cyberattack	197	1,293
Originations And Purchases Of Loans	(2,745)	(2,225)
Repayments and maturities of loans	1,424	588
Cash received from dispositions and other strategic transactions, net	1,091	109
Other, net	199	(90)
Cash flows used for investing activities	(4,245)	(1,516)
Financing activities
Common share repurchases	(1,646)	(5,545)
Cash dividends paid	(4,092)	(3,912)
Proceeds from common stock issuances	359	581
Repayments of long-term debt	(2,500)	0
Repayments of short-term borrowings, net	(2,313)	(1,403)
Proceeds from Issuance of Long-Term Debt	0	2,969
Customer funds administered	332	(25)
Other, net	(1,755)	(513)
Cash flows used for financing activities	(11,615)	(7,848)
Effect of exchange rate changes on cash and cash equivalents	(3)	29
Increase in cash and cash equivalents, including cash within businesses held for sale	4,101	3,309
Less: net change in cash within businesses held for sale	119	(25)
Net increase in cash and cash equivalents	4,220	3,284
Cash and cash equivalents, beginning of period	24,365	25,312
Cash and cash equivalents, end of period	$ 28,585	$ 28,596

Condensed Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 28,585	$ 24,365
Short-term investments	2,883	3,756
Accounts receivable, net	21,573	23,018
Other current receivables, net	24,722	29,697
Prepaid expenses and other current assets	9,097	9,746
Total current assets	86,860	90,582
Long-term investments	57,716	54,251
Property, equipment and capitalized software, net	10,762	10,762
Goodwill	110,645	110,499
Other intangible assets, net	19,749	20,474
Other assets	23,995	23,013
Total assets	309,727	309,581
Current liabilities:
Medical costs payable	38,930	39,337
Accounts payable and accrued liabilities	39,741	38,032
Short-term borrowings and current maturities of long-term debt	3,827	6,069
Unearned revenues	2,986	3,413
Other current liabilities	26,336	28,046
Total current liabilities	111,820	114,897
Long-term debt, less current maturities	69,501	72,320
Deferred income taxes	2,722	2,421
Other liabilities	19,735	18,245
Total liabilities	203,778	207,883
Commitments and contingencies (Note 7)
Redeemable noncontrolling interests	1,436	1,608
Equity:
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.01 par value - 3,000 shares authorized; 905 and 906 issued and outstanding	9	9
Additional paid-in capital	0	559
Retained earnings	100,957	95,603
Accumulated other comprehensive loss	(2,519)	(2,061)
Nonredeemable noncontrolling interests	6,066	5,980
Total equity	104,513	100,090
Total liabilities, redeemable noncontrolling interests and equity	$ 309,727	$ 309,581
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10	10
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	3,000	3,000
Common stock, shares issued	905	906
Common stock, shares outstanding	905	906